Shoffner J M, Brown M D, Stugard C, Jun A S, Pollock S, Haas R H, Kaufman A, Koontz D, Kim Y, Graham J R
Department of Genetics and Molecular Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
Ann Neurol. 1995 Aug;38(2):163-9. doi: 10.1002/ana.410380207.
A novel point mutation in the ND6 subunit of complex I at position 14,459 of the mitochondrial DNA (MTND6LDY T14459A) was identified as a candidate mutation for the highly tissue-specific disease. Leber's hereditary optic neuropathy plus dystonia. Since the MTND6LDYT14459A mutation was identified in a single family, other pedigrees with the mutation are needed to confirm its association with the disease. Clinical, biochemical, and genetic characterization is reported in two additional pedigrees. Leber's hereditary optic neuropathy developed in two family members in one pedigree. The daughter had clinically silent basal ganglia lesions. In a second pedigree, a single individual presented with childhood-onset generalized dystonia and bilateral basal ganglia lesions. Patient groups that included individuals with Leigh's disease, dystonia plus complex neurodegeneration, and Leber's hereditary optic neuropathy did not harbor the MTND6LDYT14459A mutation, suggesting that this mutation displays a high degree of tissue specificity, thus producing a narrow phenotypic range. These results confirm the association of the MTND6LDYT14459A mutation with Leber's hereditary optic neuropathy and/or dystonia. As the first genetic abnormality that has been identified to cause generalized dystonia, this mutation suggests that nuclear DNA or mitochondrial DNA mutations in oxidative phosphorylation genes are important considerations in the pathogenesis of dystonia.
线粒体DNA(MTND6LDY T14459A)复合体I的ND6亚基第14459位的一个新的点突变被确定为高度组织特异性疾病——Leber遗传性视神经病变合并肌张力障碍的候选突变。由于MTND6LDYT14459A突变仅在一个家族中被发现,因此需要其他携带该突变的家系来证实其与该疾病的关联。本文报道了另外两个家系的临床、生化和遗传学特征。在一个家系的两名家庭成员中出现了Leber遗传性视神经病变。该家系的女儿有临床上无症状的基底神经节病变。在第二个家系中,一名个体表现为儿童期起病的全身性肌张力障碍和双侧基底神经节病变。包括Leigh病、肌张力障碍合并复杂神经变性以及Leber遗传性视神经病变患者在内的患者群体均未携带MTND6LDYT14459A突变,这表明该突变具有高度的组织特异性,因此产生的表型范围较窄。这些结果证实了MTND6LDYT14459A突变与Leber遗传性视神经病变和/或肌张力障碍之间的关联。作为首个被确定可导致全身性肌张力障碍的遗传异常,该突变表明氧化磷酸化基因中的核DNA或线粒体DNA突变是肌张力障碍发病机制中的重要考虑因素。